On December 9, Virgin Galactic announced a capital realignment that includes issuing $46 million in new equity and placing $203 million of first-lien notes due in 2028 at a 9.8 percent coupon. The equity issuance involves approximately 12.1 million new shares with attached warrants exercisable at 155 percent of the equity issuance price. The new debt will replace existing convertible notes at a 2.5 percent rate, extending the maturity profile by one year to December 31, 2028, and reducing total debt from $425 million to $273 million.

Existing shareholders face significant dilution as shares outstanding rise from 63.2 million to 104.1 million—a 65 percent increase. The warrant attach rate on the debt placement could add up to 30.3 million shares if fully exercised. This dilution, combined with the equity issuance at a price below recent trading levels, triggered a swift 16 percent drop in market value and continued share weakness over the following three weeks, culminating in a more than 30 percent decline from pre-announcement levels.

Management plans to resume commercial flights with the Delta-class spaceplane, targeting flight testing in Q3 2026 and service launch in Q4 2026. With about 800 tickets already sold at prices between $200,000 and $250,000, the company expects to clear its backlog by end-2027. By 2028, Virgin Galactic forecasts selling new tickets at $600,000 apiece to approximately 750 passengers annually, generating $450 million in revenue. If executed on schedule, these operations could enable the company to cover interest costs and achieve its first profitable year.